- Home
- Supplements
- Triphala
- Chronic Constipation
Triphala for Chronic Constipation
Small randomized trials show Triphala improves stool frequency and consistency in functional constipation, and it does so without the dependency pattern associated with stimulant laxatives.
Overview
Verdict
The direction of effect is consistent and the mechanism is sensible, but the trials are small, mostly unblinded and largely conducted by proponents.
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 1-3 g powder at night
- Expected timeframe
- 3-7 days for stool change; 2-4 weeks for a settled pattern
Protocol
- form
- Triphala churna (powder) or standardised extract - the traditional preparation combines amalaki, bibhitaki and haritaki
- duration
- 4 weeks
- co factor
- Take at night, on an empty stomach or two hours after food, with warm water. Evidence is mixed: small trials and traditional use support a mild laxative effect, largely attributed to haritaki, but the trials are low-quality, mostly unblinded and small, and formulation varies widely between products.
- titration
- Increase to 2-3 g at night over one to two weeks if needed; trials have used up to 5 g/day
- starting dose
- 1 g triphala powder or extract at night with warm water
Evidence
What the studies say
Therapeutic Uses of Triphala in Ayurvedic Medicine
Peterson CT, Denniston K, Chopra D
Triphala shows laxative, antioxidant, anti-inflammatory and antimicrobial activity with limited human trial evidence
Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders
Tarasiuk A, Mosinska P, Fichna J
Triphala improved bowel frequency and consistency in small human studies via laxative and prokinetic mechanisms
Safety
Caveats
Triphala contains anthraquinone-type constituents with stimulant laxative activity - do not use long-term, and stop if you become dependent on it for bowel movements. Cramping and diarrhoea are common at higher doses. Do not use in suspected bowel obstruction, and be cautious in inflammatory bowel disease. Safety ceiling: above 5 g/day is unstudied; prolonged stimulant laxative use can cause electrolyte disturbance, particularly with diuretics or digoxin. Ayurvedic products carry a documented heavy-metal contamination risk - use third-party tested brands. Contraindicated in pregnancy (uterine stimulant potential) and not established in breastfeeding. New constipation after 50, or with bleeding or weight loss, needs investigation. Psyllium and adequate fluid have better evidence.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.